Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma

MLA

Anna Dimberg, et al. Agonistic CD40 Antibody Therapy Induces Tertiary Lymphoid Structures but Impairs the Response to Immune Checkpoint Blockade in Glioma. Jan. 2021. EBSCOhost, https://doi.org/10.1101/2021.01.05.425377.

APA

Anna Dimberg, Joey Lau, Maria H. Ulvmar, Asgeir Store Jakola, Anja Smits, Sylwia Libard, Hua Huang, Maria Zetterling, Konstantinos Vazaios, Luuk van Hooren, Mikael C. I. Karlsson, Maria Georganaki, Thomas Olsson Bontell, Alessandra Vaccaro, Magnus Essand, Tiarne van de Walle, Ilkka Pietilä, Sara M. Mangsbo, & Mohanraj Ramachandran. (2021). Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma. https://doi.org/10.1101/2021.01.05.425377

Chicago

Anna Dimberg, Joey Lau, Maria H. Ulvmar, Asgeir Store Jakola, Anja Smits, Sylwia Libard, Hua Huang, et al. 2021. “Agonistic CD40 Antibody Therapy Induces Tertiary Lymphoid Structures but Impairs the Response to Immune Checkpoint Blockade in Glioma,” January. doi:10.1101/2021.01.05.425377.